Top 3 SPAC Targets – Pharma Manufacturers
As discussed in the last iteration of this column focused on late-stage biotech firms, SPACs have increasingly turned to the drug development sector as a safe space on the board while various types of volatility have cropped up in the fourth quarter of 2026. ...READ MORE
Podcast – The Robotaxi Pure-Play: Inside May Mobility’s $1.48 Billion SPAC Deal (ACGC)
This week, we speak with Edwin Olson, CEO and Co-founder of May Mobility, and Andrew Sung, President and CFO of ACP Holdings Acquisition Corp. (NASDAQ:ACGC) to discuss the $1.48 billion business combination they announced in September. ...READ MORE
